Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction.
Frank Erhard UschnerKathleen GlückertRafael PaternostroThorsten GnadRobert SchierwagenMattias MandorferFernando MagdalenoCristina OrtizKatharina Maria SchwarzkopfPatrick S KamathCarlo AlessandriaChristoph BoeseckeAlexander PfeiferThomas ReibergerWolfgang KreiselTilman SauerbruchArnulf FerlitschJonel TrebickaSabine KleinPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
ED is common with advanced cirrhosis and concomitant NSBB treatment. The combination of PDE-5-I and NSBB improves ED and PH in experimental cirrhosis.